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CD8 Binding to MHC Class I Molecules
Is Influenced by T Cell
Maturation and Glycosylation
to be upregulated during T cell activation (Kane and
Mescher, 1993; Luescher et al., 1995; O’Rourke et al.,
1990). In addition to its role in mature T cell responses,
a variety of experiments suggest that CD8 interactions
(both cognate and noncognate) can play an important
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gested TCR-independent binding of class I MHC tetra-
mers to CD8 on thymocytes, while we and others have
observed little evidence for CD8 binding to class I tetra-Summary
mers in the absence of a cognate TCR interaction on
mature T cells (Altman et al., 1996; Busch et al., 1998;CD8 serves both as an adhesion molecule for class I
MHC molecules and as a coreceptor with the TCR for Daniels and Jameson, 2000; Murali-Krishna et al., 1998).
In order to explain this discrepancy, we sought toT cell activation. Here we study the developmental
regulation of CD8-mediated binding to noncognate determine whether binding of class I MHC tetramers to
CD8 changes during T cell maturation. Here we showpeptide/MHC ligands (i.e., those not bound by the
TCR). We show that CD8’s ability to bind soluble class the ability of CD8 to bind class I MHC ligands diminishes
as T cells develop from immature double-positive (DP)I MHC tetramers and to mediate T cell adhesion under
shear flow conditions diminishes as double-positive thy- to mature CD8 SP cells. Further experiments suggested
that a critical factor in this maturation effect is the glyco-mocytes mature into CD8 T cells. Furthermore, we pro-
vide evidence that this decreased CD8 binding results sylation state of the developing thymocyte—specifically
that sialylation inhibits CD8’s ability to bind to class Ifrom increased T cell sialylation upon T cell matura-
tion. These data suggest that CD8’s ability to interact ligands. We also show that these effects drastically alter
the ability of CD8 to mediate T cell adhesion to class Iwith class I MHC is not fixed and is developmentally
regulated through the T cell’s glycosylation state. molecules under shear flow conditions.
Introduction Results
CD8 is involved in recognition of class I MHC molecules The Nature of the Noncognate
by developing thymocytes and mature cytotoxic T lym- Tetramer/CD8 Interaction
phocytes (CTL) (Janeway, 1992; Miceli and Parnes, Bosselut and colleagues showed that H-2Dk tetramers
1993; Zamoyska, 1994). On murine T cells, CD8 is typi- can bind thymocytes through direct interaction with
cally a heterodimer consisting of  and  chains, al- CD8 (Bosselut et al., 2000). We had not observed
though it can be expressed as an  homodimer on a similar H-2Kb tetramer binding to CD8 alone in our stud-
distinct subset of lymphocytes (Zamoyska, 1994). CD8 ies of mature peripheral CD8 T cells, although a role for
can act as a coreceptor, participating in the “cognate” CD8 in TCR cognate interactions could clearly be seen
recognition of peptide-MHC I by the TCR (Janeway, (Daniels and Jameson, 2000). To account for these discor-
1992; Miceli and Parnes, 1993; Zamoyska, 1994). Such dant results, we considered that either the MHC allele
coreceptor functions of CD8 may involve both stabiliza- and/or the developmental stage of the T cell influenced
tion of the TCR/MHC-peptide complex (Garcia et al., the capacity of CD8 to bind noncognate MHC class I.
1996) and signal amplification by virtue of CD8 associa- Accordingly, we stained B6 thymocytes with a titration
tion with Lck (Miceli and Parnes, 1993; Thome et al., of increasing concentrations of Dk/MT and Kb/OVA tetra-
1996), LAT (Bosselut et al., 1999), and lipid rafts (Arcaro mers. Both tetramers showed a dose-dependant staining
et al., 2000). Alternatively, CD8 can bind class I mole- of bulk thymocytes (mostly CD48 DP thymocytes) but
cules independently of the TCR (“noncognate” class I not of CD48 (CD4SP) thymocytes (Figure 1A). Dk/MT
binding) and in this way can act as an adhesion molecule staining was consistently higher than that seen with
(Norment et al., 1988), a property which has been shown Kb/OVA tetramer, and since it has previously been shown
there is a direct correlation between the level of tetramer
staining and the affinity for its ligand (Crawford et al.,5 Correspondence: james024@tc.umn.edu
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Figure 1. The Nature of the Noncognate Tet-
ramer/CD8 Interaction
(A and B) B6 thymocytes were stained with
increasing concentrations of Kb/OVA () and
Dk/MT () tetramers in the absence (A) and
presence (B) of CD4 and CD8 (53-6.7) anti-
bodies. In (B), the staining is shown for the
CD48 DP population. Dk/MT tetramer stain-
ing on CD4 SP cells (H17009) is shown in both
panels as the negative control.
(C–E) B6 thymocytes were stained with Kb/OVA
(C), Dk/MT (D), and Kb/SIY (E) tetramers, with
or without CD4 and CD8 antibodies. Tetramer
staining is shown for the total thymocyte pop-
ulation (mostly DP thymocytes) without anti-
bodies (dotted histogram) or with the anti-
CD8 antibodies 53-6.7 (open) or with CTCD8a
(black). Tetramer staining of CD4 SP cells
(gray) is shown as a negative control.
1998; Daniels and Jameson, 2000), this may mean that that the T cells studied here are polyclonal thymocytes
and, as such, tetramer binding is unlikely to involve anyCD8 has a higher affinity for Dk than Kb. Nevertheless,
thymocytes demonstrated detectable binding to tetra- contribution by a specific TCR. Indeed, we also found
that such staining was observed on TCR/ DP thymo-mers of both allelic forms.
Thymocyte subsets are classically defined using CD4 cytes, which cannot express a mature  TCR (see be-
low), and on COS fibroblast cells transfected with mouseand CD8 antibodies. Therefore, to determine the thymo-
cyte populations which bound these tetramers, we first CD8 (L.D. and P.K., unpublished data).
needed to test the impact of CD8 antibodies on tetramer
binding. In previous work, we showed that some CD8 Noncognate Tetramer Binding Decreases
with Thymocyte Developmentand CD8 antibodies block cognate tetramer staining,
while others have no effect or even enhance specific The ability of thymocytes to bind noncognate Kb-based
tetramers is in stark contrast to what we have previouslybinding (Daniels and Jameson, 2000). Indeed, the CD8-
specific antibody 53-6.7, which we and others have shown for peripheral CD8 T cells, in which we showed
that tetramer staining faithfully reflected TCR fine speci-shown stabilizes TCR/CD8/MHC interactions (Daniels
and Jameson, 2000; Luescher et al., 1995), dramatically ficity, even in the presence of saturating amounts of
enhancing anti-CD8 antibodies (Daniels and Jameson,enhanced binding of both Dk and Kb tetramers while
preserving the hierarchy of binding seen in the absence 2000). Consequently, we explored whether noncognate
MHC I/CD8 binding changed during T cell development.of CD8 antibodies (Figures 1B–1E). In contrast to the
enhancing effect of 53-6.7, the CD8-specific CT-CD8a B6 thymocytes were incubated with anti-CD4, anti-
CD8 (53-6.7), and Kb/OVA tetramer and gated as shownantibody inhibited tetramer staining (Figures 1C–1E).
Likewise, anti-CD8 antibodies KT-112 enhanced non- in Figure 2A. CD4 SP thymocytes did not bind class I
MHC tetramers and were used to establish the negativecognate binding to CD8, and 53-5.8 blocked noncognate
CD8 binding (data not shown). These patterns of aug- control (Figures 2B–2F). DN thymocytes were unable to
bind Kb/OVA tetramers as would be expected becausementation and inhibition are identical to those we re-
ported for tetramer binding to TCR-specific T cells (Dan- they lack CD8 expression (Figure 2B). Conversely, DP
thymocytes displayed substantial binding of Kb/OVA tet-iels and Jameson, 2000). It should be stressed, though,
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Figure 2. Noncognate Tetramer Binding Decreases with Thymocyte Development
B6 thymocytes were stained with CD4, CD8 (53-6.7) antibodies, and Kb/OVA tetramer.
(A) The thymocyte subsets defined by CD4 and CD8 staining are listed as “B” through “F”.
(B–F) Tetramer staining in each of these subsets is indicated (open histogram) with staining of the CD4 SP subset acting as negative control
(gray histogram).
ramer (Figure 2C). As DP thymocytes go through selec- teractions, as would be expected for CD8 noncognate
class I binding.tion, they downregulate both coreceptors, becoming
CD4loCD8lo, and this population bound the Kb/OVA tetra-
mer with much less efficiency than DP thymocytes (Fig- Positive Selection of DP Thymocytes Diminishes
CD8/Class I Bindingure 2D), perhaps due to their lower expression of CD8.
Similarly, CD48lo intermediate thymocytes were unable Next we asked whether CD8/class I interactions were
altered by thymic positive selection of the DP popula-to efficiently bind Kb/OVA tetramer (Figure 2E). Remark-
ably, CD4, 8 (CD8 SP) bound tetramer poorly (Figure tion. Hence we compared the noncognate tetramer
staining of DP thymocytes from three mouse strains:2F), despite the fact that these cells display at least as
much CD8 on their cell surface as DP thymocytes (Figure TCR/, OT-I, and OT-I TAP/. DP thymocytes de-
velop in TCR/ mice but cannot undergo positive se-2A). These data suggest developmental regulation of
CD8/class I MHC interactions. lection, since they lack a mature  TCR (Mombaerts
et al., 1992). At the other extreme, positive selectionIt was formally possible that the change in Kb tetramer
staining of B6 thymocytes during T cell maturation was among OT-I T cells on a B6 background is highly effi-
cient, due to the transgenic  receptor. In contrast,due to Kb-specific negative or positive selection. This
was ruled out by examination of Kb/OVA tetramer stain- OT-I CD8 T cell positive selection is markedly reduced
in the TAP/ background, due to the lack of selectinging of thymocytes from H-2d and H-2k haplotype mice
(Figure 3). The lower tetramer staining on mature CD8 class I MHC ligands (Hogquist et al., 1997). Intriguingly,
Dk/MT tetramer staining intensity followed the seriesT cells when compared to immature CD8 DP cells was
similar in all of these strains. Furthermore, similar stain- OT-IOT-I TAP/ TCR/ (Figure 4A), and a similar
hierarchy was seen using Kb/SIY tetramers (data noting profiles were obtained using other Kb or Dk/MT tetra-
mers regardless of the H-2 haplotype of the mouse shown). In similar experiments, tetramer staining of wild-
type B6 DP thymocytes was similar to that of TCR/strain, although, as in Figure 1, Dk tetramer staining was
generally more intense than Kb tetramer staining (data DPs (data not shown). These data suggested first, that
CD8 binding to noncognate ligands was not equivalentnot shown). These data suggest the binding is indepen-
dent of TCR repertoire and/or peptide/MHC-specific in- for all DP cells and second, that tetramer staining inten-
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Figure 3. Noncognate Tetramer Binding Is Not Influenced by Thy-
mocyte MHC Haplotype
Thymocytes and mature lymph node T cells from B6 (A), BALB/c
(B), and C3H (C) mice were stained with Kb/OVA tetramer in the
presence of antibodies to CD4 and CD8 (53-6.7). In each case,
Kb/OVA tetramer staining is show for DP (open histogram), CD8
SP (dotted histogram), and CD4 SP thymocytes (gray histogram),
and for CD8 lymph node cells (black histogram).
sity inversely correlated with the induction of thymic
positive selection among the DP populations. Similar
patterns of tetramer staining were observed with DP Figure 4. DP Populations from Different Strains of Mice Show Vari-
thymocytes from two other class I-restricted TCR trans- ability in CD8 Binding to Noncognate Class I Tetramers
genic strains (H-Y and 2C) and a class II MHC restricted Thymocytes from TCR/ (black histogram), OT-I (open), and OT-I
TCR transgenic strain (DO11.10): each transgenic DP TAP/ (gray) mice were stained with Dk/MT tetramers (A), anti-CD3
antibody (B), and/or PNA (C) simultaneously with CD4 and CD8 (53-population stained less intensely than wild-type thymo-
6.7) antibodies. Staining is shown for CD48 DP thymocytes incytes with noncognate tetramers (data not shown).
each case.Again, these data suggest that positive selection nega-
tively influences the ability of CD8 to bind noncognate
class I directly.
activation of mature CD8 T cells, and at least some ofHow might thymic maturation in general and positive
these differences relate to sialylation (Casabo et al., 1994;selection in particular alter CD8’s ability to engage class
Wu et al., 1996). Indeed, PNA staining shows a hierarchyI MHC? One well-established change that occurs as DP
(albeit subtle) in the order OT-I  OT-I TAP/ thymocytes undergo positive selection and maturation
TCR/, matching the hierarchy of tetramer stainingis an increase in levels of surface TCR (Robey and Fow-
(Figure 4C).lkes, 1994). We see this progression in the analysis of
Therefore, further experiments were performed to testthe three strains above with CD3 levels following the
whether TCR levels and/or surface sialylation contrib-hierarchy TCR/  OT-I TAP/OT-I, i.e., opposite
uted to the changes in CD8/class I binding observedto the hierarchy for tetramer staining (Figure 4B). One
during thymocyte development.could hypothesize that increased TCR expression levels
might have a detrimental effect on direct CD8/class I
interactions, perhaps by physically restraining CD8’s
The Role of Cell Surface TCR Expression Levelability to bind noncognate ligands.
on CD8/Class I BindingAnother change reported to occur during thymic se-
There was an impressive inverse correlation betweenlection is increased cell surface sialylation. This is re-
TCR levels and noncognate tetramer staining (Figure 4).flected by decreased staining with PNA as T cells mature
If elevated TCR expression inhibited CD8/class I non-(Fowlkes et al., 1980; Reisner et al., 1976). PNA is a
cognate binding, we would expect that downregulationgalactose binding lectin which can bind unsialylated
of surface TCRs on mature thymocytes would lead toGal1-3GalNAc-Ser/Thr (core-1) O-glycans (Pereira et
an increase in CD8 binding. To test this, OT-I thymocytesal., 1976; Varki et al., 1999). More specifically, it has
were induced to downregulate TCR levels by antigen-been shown that CD8 itself undergoes changes in glyco-
sylation during development in the thymus and following driven internalization, and their binding to Dk/MT tetra-
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CD8 T cells was observed after neuraminidase treat-
ment, reflecting desialylation (Figures 6A and 6B). PNA
staining also increased on neuraminidase-treated im-
mature DP (Figures 6A and 6B), as has been reported
previously (Wu et al., 1996), indicating some low-level
cell surface sialylation on this population.
Remarkably, neuraminidase treatment led to a dra-
matic increase in noncognate class I tetramer staining
among the CD8 populations. Staining of desialylated
CD8 lymph node cells with Dk/MT tetramer reached
levels similar to those on untreated DP thymocytes (Fig-
ure 6C), while neuraminidase treatment also enhanced
tetramer binding on the DP population (Figure 6D). Simi-
lar results were obtained with both Kb/OVA and Kb/SIY
tetramers (data not shown). Two controls indicate that
this tetramer binding involves CD8 engagement rather
than some form of nonspecific binding to desialylated
lymphocytes. First, tetramer staining did not appear on
the CD4 SP population after desialylation (Figure 6E).
Second, tetramer staining on neuraminidase-treated
CD8 mature cells and DP thymocytes was completely
blocked by the anti-CD8 antibody, CTCD8a (Figures
6C and 6D). Together, these data suggest a role for
sialylation in the ability of CD8 to bind to MHC class I.
T Cell Sialylation State Regulates CD8-MediatedFigure 5. Induced TCR Downregulation Does Not Affect CD8/Class
Adhesion to Class I under Shear Flow ConditionsI Interactions
Although our data using tetramer staining indicatedOT-I and B6 thymocytes were cultured alone or in the presence of
10 M OVA peptide. modulation of CD8/class interactions with development
(A and B) The cells were stained for CD4, CD8, and CD3. CD3 (A) and extent of glycosylation, it was not clear that these
and CD8 (B) staining is shown for OT-I CD8SP after OVAp (open measurements would have any consequences for CD8
histogram) or control (dotted) culture and for OVAp-treated B6 DP
function. One well-characterized functional property ofcells (gray).
CD8 is its ability to mediate cell adhesion to class I(C) The same populations of cells were stained for CD4, CD8 (53-6.7),
molecules displayed on APC or artificial surfacesand Dk/MT tetramer. Staining of OVAp-treated B6 DP thymocytes is
shown but was identical to untreated B6 DPs (data not shown). (Luescher et al., 1995; Norment et al., 1988; O’Rourke
et al., 1990; Sun et al., 1995). Hence, we compared the
ability of mature and immature thymocytes to adhere to
mers was measured (Figure 5). Using this approach, immobilized MHC class I ligands.
TCR expression on OT-I CD8 SP thymocytes was de- To do this using defined conditions, we allowed cells
creased to levels seen on B6 DP thymocytes (Figure to interact with plate-bound MHC class I ligands and
5A), while CD8 expression levels were unchanged (Fig- then subjected them to increasing shear flow stresses.
ure 5B). However, this extensive TCR downregulation Cell adhesion was viewed by phase contrast micros-
resulted in little, if any, enhancement of CD8 binding to copy and videotaped to determine the fraction of cells
noncognate class I tetramers (Figure 5C). Similar results that remain adhered to the plate with increasing flow.
were obtained when OT-I DP populations (which also To establish the suitability of this approach, we first
showed extensive TCR downregulation) were analyzed tested binding of CD8 OT-I lymph node T cells to plates
(data not shown). These data imply that while TCR ex- coated with Kb/OVA or streptavidin (SA). As cells were
pression per se may influence CD8 noncognate binding, subjected to maximum shear flow conditions, 88% of
it does not fully account for the change in binding we the CD8 OT-I LN remained adhered to the Kb/OVA-
observed with T cell maturation and among DPs from coated plate, while there were no cells left on the SA-
different mouse strains. coated plate (Figure 7A). Furthermore, this binding was
completely inhibited by the anti-CD8 antibody CTCD8a
(Figure 7A), in keeping with its effects on Kb/OVA tetra-The Role of T Cell Glycosylation
in CD8/Class I Interactions mer binding to OT-I cells (Daniels and Jameson, 2000),
suggesting that the cell adhesion involved CD8.To test whether differential sialylation patterns affect
noncognate tetramer binding, thymocytes and lymph We next tested whether CD8-mediated noncognate
class I adhesion could be measured in the same way.node T cells from B6 mice were treated with neuramini-
dase, which cleaves sialic acid residues from oligosaccha- Consistent with their intense staining by class I tetra-
mers (Figure 4), TCR/ DP thymocytes adhered wellrides. As controls, we followed the appearance of PNA
staining and loss of staining with the S7 antibody (which to immobilized Dk/MT molecules but not to the control
(SA alone) plate (Figure 7B). In stark contrast, maturerecognizes a sialylation-dependent epitope on CD43) fol-
lowing neuraminidase treatment (Figures 6A and 6B). A CD8 OT-I lymph node T cells were unable to adhere
to the Dk surface (Figure 7C). This lack of adhesion ismarked change in PNA and S7 staining on lymph node
Immunity
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Figure 6. Desialylation Increases CD8/Class
I Interactions on Mature T Cells
Thymocytes and lymph node cells from B6
mice were cultured in the presence and ab-
sence of neuraminidase and were then
stained for CD4 and CD8 (53-6.7) together
with FITC-PNA (A), FITC-S7 (B) antibody.
Staining of the CD48 DP and lymph node
CD8 T cells with or without neuraminidase
treatment is shown as indicated.
(C–E) In parallel, control (dotted histogram) or
neuraminidase-treated cells (open and gray
histograms) were stained with Dk/MT tetra-
mer in the presence of anti-CD8 antibodies
53-6.7 (open and dotted histograms) or
CTCD8a (gray histogram) plus anti-CD4. Tet-
ramer staining is shown for lymph node CD8
cells (C), DP thymocytes (D), and CD4 SP
thymocytes (E).
consistent with poor noncognate tetramer binding to CD8 antibody CTCD8a, which reduced adhesion to
background (SA control) levels (Figure 7D). This was notmature OT-I T cells (Figure 5). Thus, the adhesion assay
accurately reflected the differences in CD8/class I bind- a nonspecific effect of coating the cells with antibody,
since anti-CD4 antibody did not inhibit binding of theseing determined by flow cytometry.
In the same experiments, we addressed whether ad- cells (Figure 7D). Similarly, the CTCD8a antibody
blocked binding of desialylated OT-I cells to Dk/MT (datahesion could be modified by desialylation. Neuramini-
dase treatment had a marginal enhancing effect on the not shown). Analogous results were obtained when cell
adhesion to Kb/SIY and Kb/P815 complexes was studied,efficient TCR/ DP thymocyte binding to Dk/MT (Fig-
ure 7B) but had a dramatic effect on OT-I T cell adhesion suggesting that this is not a unique feature of binding
to Dk/MT (data not shown).to the same type of surface: approximately 60% of neur-
aminidase-treated OT-I cells were still bound to the These data indicate that the changes in CD8 which
occur with thymocyte development and surface sialyla-Dk/MT surface under maximum shear flow, compared
to 0% of the untreated OT-I T cell population (Figure tion state have a significant impact on the ability of CD8
to act as an adhesion molecule for class I MHC.7C). Indeed, adhesion of neuraminidase-treated OT-I
cells resembled that of the untreated TCR/ DP thy-
mocytes on the Dk/MT surface (compare Figures 7B Discussion
and 7C). We did observe slightly elevated adhesion of
neuraminidase-treated OT-I cells to the control SA plate In this study, we show that CD8 binding to noncognate
MHC class I molecules is regulated by the develop-under low shear flow conditions (Figure 7C), perhaps
reflective of some nonspecific adhesion, but this adhe- mental state of the T cell, specifically that such binding
decreases as cells mature from the DP stage.sion was lost within the first step of increasing shear
flow force, implying very weak binding. How is the CD8/class I interaction regulated during
development? Initially, we explored the possibility thatWe confirmed that the adhesion of neuraminidase-
treated TCR/ thymocytes to the Dk/MT surface was TCR expression levels negatively regulate the ability of
CD8 to bind (noncognate) class I ligands. While ourmediated by CD8 by pretreating with the blocking anti-
Glycosylation Affects CD8 Binding to Class I MHC
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Figure 7. Influence of T Cell Development
and Glycosylation on CD8-Mediated Adhe-
sion to Class I Ligands
(A) OT-I CD8 LN cells were allowed to adhere
to plates coated with streptavidin (SA) (filled
circles) or SA and bio-Kb/OVA (OVA/Kb) (open
squares and filled triangles). In some cases,
the cells were pretreated with CTCD8a anti-
body (filled triangles). The cells were subject
to increasing flow as indicated by the sche-
matic at the bottom of the figure; flow was
initiated (arrowhead) and increased in five in-
crements over 50 s (steps) to a maximum
force of 20 dynes cm2 . Adherent cells were
enumerated by video microscopy, and data
is shown as the fraction of initially adherent
T cells remaining at each video frame (1 s
intervals).
(B and C) Similar experiments were per-
formed with TCR/ (B) thymocytes and
OT-I CD8 LN cells (C). In both cases, binding
to plates coated with SA (circles) or SA plus
Dk/MT (squares) was measured using control
(filled symbols) or neuraminidase-treated
cells (open symbols).
(D) Neuraminidase-treated TCR/ thymo-
cytes were allowed to adhere to SA (filled
circles) or SA plus Dk/MT coated plates
(squares and open circles). Prior to adhesion,
some of the cells were incubated with anti-
CD4 (open squares) or anti-CD8 (CTCD8a)
(open circles) TCR/ thymocytes.
experiments using antigen-induced TCR downregula- the PNA binding site on mature T cells (Baum et al.,
1996; Galvan et al., 2000; Gillespie et al., 1993; Kono ettion argue against this effect (Figure 5), we cannot rule
out other changes which may have been induced by al., 1997; Pereira et al., 1976; Priatel et al., 2000). We
show here that desialylation of naı¨ve mature CD8 cellsT cell activation and could mask a role for the TCR. A
far more impressive correlation was observed when the enhances the ability of CD8 to bind noncognate class I
ligands. Similar conclusions were reached by Moody etglycosylation state of the developing T cells was consid-
ered. Glycosylation patterns on CD8 T cells are linked al. in a report published while this manuscript was in
press (Moody et al., 2001a). Similar to our results, theseto their maturation, their activation state, and their po-
tential for survival as naı¨ve T cells (Casabo et al., 1994; authors observed that CD8 binding to noncognate class
I tetramers could be observed on DP cells but not CD8Harrington et al., 2000; Priatel et al., 2000; Wu et al.,
1996). In both mice and humans, immature thymocytes SP thymocytes or peripheral T cells, and that this devel-
opmental change was regulated by cell surface sialyla-and activated effectors demonstrate low levels of sialy-
lation, while naı¨ve T cells are highly sialylated (Figure 5) tion levels. These authors also showed that mature CD8
SP T cells from ST3Gal-1/ mice showed enhanced(Baum et al., 1996; Casabo et al., 1994; Galvan et al.,
2000; Gillespie et al., 1993; Kono et al., 1997; Priatel et noncognate tetramer binding, suggesting an important
role for sialylation of core-1 O-linked glycans in regulat-al., 2000; Wu et al., 1996). This is very well characterized
for the changes in sialylation of Gal1-3GalNAc-Ser/Thr ing CD8 binding.
How might the sialylation of O-linked glycans influ-(core-1 O-linked glycans), which is mediated by the en-
zyme ST3Gal-1. ST3Gal-1 expression is developmen- ence CD8 binding? There is evidence for extensive
O-linked glycosylation of the “stalk” region of CD8,tally regulated, being absent in immature DP thymocytes
and upregulated during maturation into mature SP which may play a role in membrane protein-protein inter-
actions and/or membrane mobility of CD8, which con-T cells, and it is the activity of ST3Gal-1 which blocks
Immunity
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tribute indirectly to more efficient or more stable class others showed that cognate class I binding was also
enhanced with 53-6.7 Fab fragments, indicating thatI binding (Casabo et al., 1994; Moody et al., 2001a; Rudd
et al., 2001; Rudd et al., 1999). We propose that this this effect is not due to CD8 aggregation (Daniels and
Jameson, 2000; Luescher et al., 1995). The epitopesinvolves a critical contribution from the CD8 chain.
Similar to the findings of others (Bosselut et al., 2000; for 53-6.7 and CT-CD8 are distinct, as measured by
antibody binding competition (M.A.D. and S.C.J., un-Moody et al., 2001a), we find that noncognate tetramer
staining requires expression of CD8 on thymocytes (data published data) and by CD8 mutation analysis (L.D.
and P.K., unpublished data), and this may relate to theirnot shown). Furthermore, CD8 sialylation is altered during
development and CD8 T cell activation (Casabo et al., very different effects on tetramer binding. However, it
is important to note that the apparent developmental1994). Recent experimental evidence argues that the
CD8 ectodomain may bind class I most proximal to APC regulation of CD8 noncognate binding was not depen-
dent on 53-6.7 binding: this antibody was not used inmembrane (Devine et al., 1999), requiring CD8 to be ex-
tended, while at the same time CD8 ectodomains must the adhesion assays, yet we still observed profound
differences in CD8-mediated adhesion by immature DPpivot to engage the class I ligand (Kern et al., 1998),
requiring flexibility of the molecule. The extent of sialyla- versus mature CD8 T cell populations (Figure 7).
Our data revealed an inverse correlation between DPtion on the CD8 stalk may therefore be critical for opti-
mal CD8 binding. positive selection and CD8-class I binding (Figure 4). It
was somewhat surprising that the tetramer staining ofAt the same time, our desialylation experiments did
not completely eliminate the difference in class I tetra- OT-I TAP/ DP cells was not as intense as that on
TCR/, given the severe block in OT-I T cell positivemer staining observed between immature DPs and ma-
ture CD8 T cells, as was evident from the greater staining selection in the former population. We note, however,
that OT-I TAP/ DP cells do express low levels of CD69on DP thymocytes than mature cells when both are
treated with neuraminidase (Figure 6). Our experiments (data not shown), suggesting that these cells have un-
dergone some partial events in positive selection (al-involved the neuraminidase from Vibrio cholerae, which
has a fairly broad specificity cleaving 2-3, 2-6, and though insufficient to induce complete maturation). This
is in keeping with a model recently proposed by Wong2-8 sialic acid linkages. However, on certain cell-free
substrates this enzyme shows a preference for 2-3 and colleagues (Wong et al., 2001). In aggregate then,
our results suggest that CD8 noncognate class I bindinglinkages (Corfield et al., 1983), leaving open the possibil-
ity that certain sialic acid linkages may not be efficiently is downregulated by positive selection. What might be
the functional role of regulated CD8 noncognate classremoved in our experiments. Furthermore, Moody et al.
found that ST3Gal-1/ CD8 SP T cells did not bind I binding in T cell development? We showed in this report
that the noncognate interaction was sufficient to causenoncognate tetramer as well as neuraminidase-treated
cells (Moody et al., 2001a). These data suggest that CD8-mediated cell adhesion. In analogous studies using
activated CTL, it was shown that CD8 adhesion to non-numerous sialic acid linkages could be involved in regu-
lating CD8 binding. Indeed, there is evidence that 2-6 cognate class I enhanced effector functions and trig-
gered other adhesion molecule interactions (Anel et al.,sialylation is also developmentally regulated in the thy-
mus (Baum et al., 1996). Alternatively, there are other 1996; O’Rourke and Mescher, 1993; O’Rourke et al.,
1990). Similarly, efficient CD8/class I binding could en-differences in glycosylation that may play a role in medi-
ating the effect. For example, it is known that core-2 hance immature thymocyte adhesion to thymic epithelial
cells. Moreover, optimal CD8 binding at the DP stageO-linked glycans are expressed on cell surface proteins
of immature thymocytes and that sialylation of core-1 might concentrate potential selecting MHC ligands for
examination by the TCR by retaining class I moleculesby ST3Gal-I in mature T cells inhibits the core-2 pathway,
presumably through a mechanism that involves compe- in the region of T cell thymic epithelial cell contact—a
feature which could compensate for the low levels oftition for substrate (Priatel et al., 2000). Such altered
patterns of glycosylation would not be reversed by neur- TCR expression at this stage. It is noteworthy that the
immature DP stage, at which we observe most efficientaminidase treatment and may account for the differ-
ences between noncognate CD8 binding to immature CD8 binding to noncognate class I ligands, is also char-
acterized by heightened sensitivity to low-affinity TCRand mature CD8 T cells which persist after desialyla-
tion. More sophisticated experiments will be required ligands (Davey et al., 1998; Lucas et al., 1999). Therefore,
decreasing the ability of CD8 to bind class I as T cellsto test the roles of specific glycosylation patterns in
addition to those induced by general desialylation. mature may contribute to terminating the interaction
with positively selecting self-peptide/MHC ligands andLastly, our data do not rule out a role for changes in
glycosylation of other T cell surface molecules. Differen- thus could play a role in regulating self-tolerance or
survival. Indeed, there is evidence that there may be atial glycosylation may also have a consequence of
changing the lateral mobility or packing on the cell sur- specific glycosylation requirement for CD8 T cell sur-
vival, as demonstrated by profound loss of peripheralface in general. Indeed, it has been proposed that Galec-
tin-3 plays just such a role in regulating T cell activation CD8 T cells in the ST3Gal-I/ mice (Priatel et al., 2000).
At present it is not clear whether this is mediated by an(Demetriou et al., 2001).
We also demonstrated that CD8/class I binding could effect on CD8/class I interactions, but the fact that the
loss of mature CD4 T cells in ST3Gal-1/ mice is muchbe both enhanced and inhibited with appropriate CD8
antibodies, similar to the effects we reported previously less prominent supports this hypothesis.
Since CD8 interactions are critically involved in medi-for cognate interactions (Daniels and Jameson, 2000).
Thus, the antibody 53-6.7 augmented and CT-CD8 in- ating positive and negative selection of class I-restricted
T cells, it is difficult to determine the relative contributionhibited CD8 noncognate class I interactions. We and
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using a CD8 Cellect column (Cytovax Technologies, Edmonton, Al-of CD8 acting as an adhesion molecule versus its acting
berta, Canada).as a coreceptor with the TCR. Ironically, the most com-
pelling evidence for a role for noncognate class I interac-
MHC Tetramerstions in thymic development comes from analysis of
Tetrameric forms of Kb with the OVA peptide (SIINFEKL) or SIY
class II-restricted TCR transgenic T cells which aber- peptide (SIYRYYGL) and Dk bound to the MT389-397 peptide
rantly committed to the CD8 lineage. For example, in (RRLGRTLLL) have been described previously (Daniels and Jame-
son, 2000; Lukacher et al., 1999). Production of MHC I/2m/peptideCD4-deficient mice bearing the AND transgenic TCR,
multimers followed protocols described previously (Altman et al.,thymocytes develop into the CD8 lineage. This process
1996; Busch et al., 1998; Daniels and Jameson, 2000). Briefly, MHCinvolved TCR interaction with specific class II alleles
class I molecules with the Bir A recognition sequence at the carboxylbut also required exposure to class I MHC molecules
terminus and human 2m molecules were transformed and overex-
(Matechak et al., 1996). This latter interaction was not pressed in E. coli. The synthesized proteins were purified from inclu-
allele specific, leading to the conclusion that noncog- sion bodies, denatured, mixed with the appropriate peptide, and
the mixture was allowed to renature in suitable oxido-reductive con-nate CD8/class I MHC interactions were critical to T cell
ditions over 48 hr. Following dialysis and concentration, the foldedmaturation in this model (Matechak et al., 1996). Similar
monomer complexes were purified via FPLC on a Superdex 200interpretations were arrived at by other groups using
column (Pharmacia Biotech Inc., Piscataway, NJ). The monomersdifferent model systems (Kirberg et al., 1994; Yasutomo
were then biotinylated using Bir A (Auidity, Denver, CO) and repuri-
et al., 2000). These data support the concept that non- fied via FPLC. Following concentration of the appropriate sized
cognate coreceptor interactions may be important in fractions, the biotinylated MHC I/peptide complexes were mixed
with SA-PE (Molecular Probes, Portland, OR) that had been purifiedsuccessful positive selection and/or lineage commit-
by FPLC to remove aggregates, at a 4:1 molar ratio. Multimers werement. Our data imply that the ability of CD8 to undergo
used without further purification except where noted. Multimerssuch interactions changes during thymic differentiation
were tested over a range of doses for flow cytometry and wereand may be part of the dynamic “tuning” required for
typically used at 25 g/ml.
development of a tolerant but useful T cell repertoire.
Very recent reports from other groups also indicated Antibodies and Flow Cytometry
efficient CD8/class I binding by immature DP thymo- Cells (1  106 ) were stained in 100 l of FACS buffer (PBS, 1% fetal
calf serum and 3 mM azide) or RP-10 with 3 mM azide on ice at thecytes (Moody et al., 2001b; Tsujimura et al., 2001), al-
indicated times, usually 2 hr. Cells were incubated in cold FACSthough these initial studies did not correlate this CD8
buffer for 30 min prior to addition of cold staining reagents, andbinding pattern with thymic selection, nor did they deter-
plates were prechilled and kept on ice throughout staining. Typically,
mine the basis for altered CD8 binding during develop- MHC multimers (25 g/ml) and anti-CD8 antibodies (50g/ml unless
ment. Likewise, there is little data on the mechanism by stated otherwise) were added simultaneously. The following anti-
which CD8 binding is upregulated during mature CD8 CD8 antibodies were used: 53-6.7 (Pharmingen, San Diego, CA)
and CT-CD8a (Caltag, Burlingame, CA). Cells were analyzed usingT cell activation; it should be pointed out that there have
a Becton Dickinson FACSCaliber (Becton Dickinson, San Jose, CA).been no reports of noncognate tetramer interactions
Data were analyzed using both CellQuest (Becton Dickinson) andon activated CD8 effector populations, although this
FlowJo (TreeStar, San Carlos, CA) software.
population is desialylated compared to naı¨ve CD8 T cells
(Harrington et al., 2000; Priatel et al., 2000). Furthermore, TCR Downregulation
noncognate MHC binding by CD8 on effector CTL re- Thymocytes from B6 or OT-I TCR transgenic mice were incubated
quires TCR-induced activation (Anel et al., 1996; in RP10 media at 37	C in the presence or absence of 10 M OVAp
(SIINFEKL) for 30 min, after which time the cells were spun into aLuescher et al., 1995; O’Rourke and Mescher, 1993;
pellet and incubated an additional 3.5 hr. Cells were washed andO’Rourke et al., 1990), while this was evidently not re-
chilled in FACS buffer and stained for CD4, CD8, CD3 (Pharmingen,quired for the binding by immature DP thymocytes we
San Diego, CA), and MHC I/peptide tetramers as described.
study here. Whether this indicates different mechanisms
for upregulated CD8 binding in development versus ma- Neuraminidase Treatment
ture T cell activation will require further investigation. Cells were prepared as described above and incubated at 37	C at
Our data highlight the growing awareness that glyco- a concentration of 2  106 cells per ml in RPMI in the presence or
absence of 1 l (0.016 units) type II neuraminidase from Vibrio chol-sylation of lymphocytes plays a pivotal role in regulating
erae (Sigma, St. Louis, MO) per million cells for 20 min. This enzymetheir activity (Lowe, 2001; Rudd et al., 1999, 2001). In
cleaves 2-3, 2-6, and 2-8 sialic acid linkages, and the dose usedthis study we demonstrate the role of sialylation in devel-
was determined (by titration) as sufficient to induce maximal PNA
opmental regulation of class I binding by CD8 T cells. staining of mature thymocytes. Cells were then washed three times
However, similar changes in glycosylation occur during in RPMI 1640 with 10% FCS and resuspended in adhesion (RPMI
development of CD4 T cells, and it will be interesting to 1640 with 0.5% BSA) or FACS buffer.
determine whether there is similar developmental regu-
Parallel Plate Flow Chamber and Adhesion Assaylation of CD4 binding to class II.
Streptavidin (Molecular Probes, Eugene, OR) (125 l of 125 g/ml
solution) was adsorbed to a defined area on 35 mm Falcon petri
dishes (No. 1008) overnight at 4	C. The plates were washed threeExperimental Procedures
times with PBS, then incubated for a minimum of 4 hr in PBS with
or without biotinylated peptide/MHC I (125 l of 10 g/ml solution)Mice and Cells
C57BL/6 (H 2b), C3H (H 2k), Balb/c (H 2d), and TCR-deficient mice complexes. The plates were then blocked with PBS with 2% BSA
for at least 1 hr.were obtained from Jackson Labs (Bar Harbor, ME). OT-I and
TAP-1/ OT-I mice (Hogquist et al., 1997) were bred in our colony. Lymphocyte adhesion under shear stress was examined with a
parallel plate flow chamber obtained from Glycotech (Rockville, MD)All mice were generated and maintained under specific pathogen-
free conditions. Thymi and major lymph nodes were harvested, and as previously described (Walcheck et al., 1996a, 1996b). Briefly,
plates coated with the specified peptide/MHC I complexes werea single-cell suspension was generated as previously described and
was, in some cases, enriched for CD8 T cells by negative selection attached to the flow chamber containing a 5-mm-wide gasket. Shear
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flow was generated and controlled with an automated syringe pump alpha(2-6)-linked sialic acids in glycoproteins. Biochim. Biophys.
Acta 744, 121–126.(Harvard Apparatus, Natick, MA) attached to the outlet side of the
flow chamber. Cells at a concentration of 2  106 /ml in RPMI 1640 Crawford, F., Kozono, H., White, J., Marrack, P., and Kappler, J.
with 0.5% BSA were injected into the flow chamber and allowed to (1998). Detection of antigen-specific T cells with multivalent soluble
settle on the plate for 2 min, then flow rate was increased stepwise class II MHC covalent peptide complexes. Immunity 8, 675–682.
every 10 s (by a programmed set of flow rates) over the course of
Daniels, M.A., and Jameson, S.C. (2000). Critical role for CD8 in T cell
50 s in increments of 1.28 ml/min (4 dynes/cm2 shear stress)
receptor binding and activation by peptide/major histocompatibility
to a maximum of 6.4 ml/min (corresponding to 20 dynes/cm2 ).
complex multimers. J. Exp. Med. 191, 335–346.
Lymphocyte adhesion was visualized with an Olympus IX-70 in-
Davey, G.M., Schober, S.L., Endrizzi, B.T., Dutcher, A.K., Jameson,verted microscope (Melville, NY) equipped with a Panasonic color
S.C., and Hogquist, K.A. (1998). Pre-selection thymocytes are moreCCD camera (Secaucus, NJ), recorded to VHS video tape using a
sensitive to TCR stimulation than mature T cells. J. Exp. Med. 188,Panasonic S-VHS professional deck, digitized, and compressed us-
1867–1874.ing Adobe Premiere software. The compressed movies were ana-
Demetriou, M., Granovsky, M., Quaggin, S., and Dennis, J.W. (2001).lyzed using NIH Image (v1.62). The number of cells that remained
Negative regulation of T-cell activation and autoimmunity by Mgat5bound was determined relative to the number of cells that accumu-
N-glycosylation. Nature 409, 733–739.lated during the 2 min of zero flow and are displayed as fraction
bound per frame of the compressed movie (1 frame per s real Devine, L., Sun, J., Barr, M.R., and Kavathas, P.B. (1999). Orientation
time). Data are shown for the last 5 s of zero flow and the full 50 s of the Ig domains of CD8 alpha beta relative to MHC class I.
of increasing flow rates. J. Immunol. 162, 846–851.
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